IPO de Coimbra; Servico de Oncologia Medica

Coimbra 3000-075

0 studies enrolling now · 3 studies all time

What they study most

Glioblastoma, Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN), Melanoma

Studies at this site

• A Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck — Stopped early
• A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma — Completed
• A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma — Completed